Drug Approvals Analysis
🌏 NMPAExpert commentary and market intelligence for pharma strategy teams
Showing 1–12 of 27 articles
Drug Discovery Technology Market Size Tops USD 80.27 Billion by 2035
5 min
Dr. Yuki TanakaClinical Trials Outsourcing Market Size: 2026-2034 Growth Outlook
5 min
Dr. Yuki TanakaASCO26: Revolution's Daraxonrasib Phase III Data Reshapes Pancreatic Cancer Odds
oncology · 7 min
Dr. Yuki TanakaKelun-Biotech Secures New Drug Approval for SKB118: Investor and BD Guide
FDA · oncology · 5 min
Dr. Yuki TanakaAbbVie Secures FDA Approval for ImmunoGen's Elahere
FDA · rare blood cancers · 6 min
Dr. Yuki TanakaShionogi's Xocova Gains FDA Clearance for COVID-19 Post-Exposure Prevention
FDA · COVID-19 · 7 min
Dr. Sarah MitchellUCB's Bimzelx Triumph: Psoriatic Arthritis Market Implications and Competitive Landscape
FDA · psoriatic arthritis · 8 min
Dr. Yuki TanakaCDER Leadership Changes: Navigating the Impact on Pharmaceutical Strategy
FDA · 11 min
Dr. Yuki TanakaRusan Pharma Secures PMDA GMP Approval, Boosting Global Market Access
PMDA · 8 min
Dr. Yuki TanakaMerck's Phase 3 Program: Addressing the Gaps
3 min
Dr. Sarah MitchellGlycoNex Secures PMDA Approval for GNX1021 Phase I Trial
PMDA · 3 min
Dr. Yuki TanakaMannKind's Pediatric Expansion: A New Era for Afrezza
diabetes · 3 min
Dr. Yuki Tanaka